Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Harbour BioMed Announces 2023 Interim Results 2023-08-28 17:08
Meet Kuushy: Sit your way to better health 2023-08-28 16:46
Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors 2023-08-28 16:30
Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan 2023-08-28 11:42
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy 2023-08-28 04:00
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial 2023-08-25 20:58
Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA 2023-08-25 20:00
Tigermed Reports 2023 Interim Results 2023-08-25 18:39
Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 clinical Trial of SK10, in Development for Treatment of Chemotherapy-induced Diarrhea 2023-08-25 18:19
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics 2023-08-25 15:14
Laekna, Inc. (2105.HK) Announces Interim Results 2023 2023-08-25 08:00
Ping An Health announces 2023 interim results 2023-08-24 21:00
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management 2023-08-24 20:00
Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA 2023-08-24 20:00
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results 2023-08-24 14:00
PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint Development of Novel Synthetic Peptide Based Growth Factor 2023-08-24 09:51
Samsung Biologics appoints new leadership to oversee quality and regulatory affairs 2023-08-24 07:59
Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023 2023-08-24 04:15
Complete Genomics Garners the Prestigious 2023 R&D 100 Awards for Cutting-Edge Innovation 2023-08-23 23:00
CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2023 INTERIM RESULTS (H SHARES) 2023-08-23 20:34
1 78 79 80 81 82 812